Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ

$3.56

$-0.07

(-1.93%)

Pre-Market

Recursion Pharmaceuticals, Inc. (RXRX) Live Price Chart

Last updated: ⁦2026-10-20 12:25:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Recursion Pharmaceuticals, Inc. (RXRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.56, with a market capitalization of $1.86B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.77 to $7.18. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.86B
Open	$3.63
Day's High	$42.81
Day's Low	$2.77
Previous Close	$3.61
Volume	122.68K
Average Volume	21.76M
P/E Ratio	--
52-Week High	$7.18
52-Week Low	$2.77
Dividend Yield	--
Earnings Date	--

Recursion Pharmaceuticals, Inc. (RXRX) Pre-Market Stock Price

Recursion Pharmaceuticals, Inc. (RXRX) is trading at $3.56 in pre-market trading as of 2026-10-20 12:23:00, down 1.52% ($0.05) from the previous close of $3.61

Pre-market trading shows how investors are pricing RXRX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Recursion Pharmaceuticals, Inc. (RXRX) 7-Day Stock Price Change

Over the past seven days, Recursion Pharmaceuticals, Inc. (RXRX) moved from $4.36 to $3.56, representing a decline of 18.46% ($0.81).

The stock traded between $3.44 and $4.43 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 33.06 million shares, down versus the previous seven-day period, indicating lower trading activity.

RXRX 52-Week Price Position

Position in Range: 17.8%

52W Low$2.77

52W High$7.18

RXRX is currently trading at $3.56, placing it 17.8% of the way from its 52-week low of $2.77 to its 52-week high of $7.18. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Recursion Pharmaceuticals, Inc. (RXRX)?

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Recursion Pharmaceuticals, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	600
Exchange	NASDAQ
Company Website	https://www.recursion.com

How to Buy Recursion Pharmaceuticals, Inc. (RXRX) Stock on MEXC

Eligible investors can buy real shares of Recursion Pharmaceuticals, Inc. (RXRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RXRX and Place Your Order

Open the RealStocks trading page and search for RXRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Recursion Pharmaceuticals, Inc. (RXRX) stock price today?

Recursion Pharmaceuticals, Inc. (RXRX) is currently trading at $ 3.56, down 1.52% ($0.05) from the previous close of $ 3.61. Intraday prices update in real time during regular trading hours.

2.Is RXRX stock going up or down today?

As of 2026-10-20 12:23:00, RXRX is trading at $ 3.56, down 1.52% ($0.05) from its previous close of $ 3.61. The stock has traded between $ 2.77 and $ 42.81 during today’s regular session. Past price movements do not guarantee future results.

3.What is RXRX pre-market price?

As of 2026-10-20 12:23:00, RXRX is trading at $ 3.56 in pre-market trading, down 1.52% ($0.05) from the previous close of $ 3.61. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RXRX after-hours price?

As of 2026-10-20 12:23:00, RXRX is trading at $ 3.64 in after-hours trading, up 0.80% ($0.03) from the regular-session close of $ 3.61. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RXRX stock trading now?

RXRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RXRX sit relative to its 52-week high and low?

Over the past 52 weeks, RXRX has traded between a low of $ 2.77 and a high of $ 7.18. At $ 3.56, the stock is positioned 17.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Recursion Pharmaceuticals, Inc. in?

Recursion Pharmaceuticals, Inc. (RXRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Recursion Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Recursion Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.86B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RXRX valued in terms of P/E ratio and EPS?

RXRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.97. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Recursion Pharmaceuticals, Inc. pay a dividend?

Recursion Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.